Skopos Bio develops radiopharmaceuticals aimed at targeting cancer cells more effectively than traditional methods. The company focuses on innovative treatments for a broader range of cancers, leveraging advanced imaging and radiation techniques.
Founded
1958
Total Funding
$1M+
Total Rounds
1
First Raise
Oct 2, 2026
Latest Raise
Oct 2, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/2/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free